基金早班车丨港股结构性行情延续，基金经理看好结构性机会

Group 1: Market Overview - The Hong Kong stock market is experiencing a recovery with innovative pharmaceuticals and internet platforms leading the gains, as institutional investors continue to seek structural opportunities in 2026 [1] - After two years of valuation compression, the overall Hong Kong stock market is at historical lows, with innovative drug pipelines entering a harvest phase and platform-based internet companies showing stable cash flows [1] - High-dividend central enterprise assets are highlighted for their defensive characteristics, suggesting that these three categories of stocks are likely to benefit from profit upgrades and capital inflows [1] Group 2: Fund News - On January 8, 12 new funds were launched, primarily mixed and equity funds, with the招商中证有色金属矿业主题ETF联接A aiming to raise 3 billion yuan [2] - A total of 11 funds announced dividends, with the华富天鑫灵活配置混合型证券投资基金 distributing the highest dividend of 0.5000 yuan per 10 fund shares [2] - In early 2026, 19 public funds, including华商, 银河, and泰康, launched fee reductions, indicating a shift from scale-driven to quality competition in the industry [2] Group 3: Fund Dividends - The华富天鑫灵活配置混合A fund will distribute a dividend of 0.5000 yuan per 10 shares on January 9, 2026 [4] - The安信永鑫增强债券A and C funds will each distribute a dividend of 0.0500 yuan per 10 shares on the same date [4] - The华泰柏瑞中证红利低波ETF联接 funds will also distribute dividends of 0.0500 yuan per 10 shares on January 9, 2026 [4]